U.S. General Merchandise and Department Stores Stock News

Kosmos Energy recently reported that its Jubilee field in Ghana delivered higher output with the J76 well contributing about 20,000 barrels of oil per day and strong LNG cargo liftings from the Greater Tortue Ahmeyim project in Mauritania and Senegal, while also completing the sale of its Ceiba and Okume assets in Equatorial Guinea. At the same time, Kosmos faced a new Sell rating focused on leverage and execution risk, highlighting the tension between improving operational performance and...

Ascendis Pharma (NasdaqGS:ASND) reported new 104 week data from its pivotal ApproaCH trial of once weekly TransCon CNP in children with achondroplasia. The long term results show sustained improvements in lower extremity alignment and growth outcomes, with continued safety and tolerability over two years of treatment. The company also highlighted that YUVIWEL, the commercial name for TransCon CNP, is approved in the US and remains under regulatory review at the EMA in Europe. Ascendis...

Viper Energy (VNOM) recently closed a shelf registration tied to an offering of 3,691,796 Class A common shares, totaling about US$156.6 million. This event can shape perceptions of its capital-raising flexibility. See our latest analysis for Viper Energy. Against the backdrop of this shelf registration closing, Viper Energy’s recent share price performance has been mixed, with a 7 day share price return of 3.14%, a 30 day share price return down 5.30%, and a 1 year total shareholder return...

VNET Group has delivered a very large 3 year return while the broader valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation at the current share price of US$8.01. Over the past 3 years, VNET Group has returned about 188.1%, which puts past investors well ahead but raises the bar for what needs to go right from here. China's planned US$295b buildout of data center and artificial intelligence infrastructure can support expectations for VNET Group's future...

Delta Air Lines (DAL) has just posted Q2 2026 revenue of US$19.8 billion with basic EPS of US$2.45 and net income of US$1.6 billion, setting a clear marker for this earnings season. Over the past few quarters, revenue has moved from US$14.0 billion in Q1 2025 to US$15.9 billion in Q1 2026 and now US$19.8 billion in Q2 2026. Quarterly EPS has ranged from US$0.37 in Q1 2025 to US$3.28 in Q2 2025 and US$2.45 this quarter. With trailing 12 month EPS at US$6.07 and net income of US$4.0 billion,...

In recent days, CSW Industrials has drawn attention after Zacks Equity Research highlighted the company as a top-ranked stock with an expected 20.6% year-over-year earnings increase, supported by a history of earnings beats in three of the last four quarters. At the same time, differing valuation models and recent insider selling have created a mixed picture, underscoring how much of the current investment case rests on CSW Industrials continuing to deliver strong cash flows and margins to...

Rising US Treasury yields and stress in government debt markets are not just abstract headlines; they can ripple straight through to your portfolio. With primary dealers now net short Treasuries and absorbing more supply becoming harder, funding costs and market volatility are back in focus. Some investors are looking for stocks that may benefit if higher yields support margins or attract cash into cash-like instruments. This article explains how that backdrop relates to US regional banks and...

Recent commentary has highlighted ongoing margin pressures at BJ's Wholesale Club Holdings, including below-industry gross and operating margins and slower revenue growth, intensifying scrutiny of its cost structure and competitive position. This focus on weaker profitability versus larger warehouse rivals raises fresh questions about how BJ’s scale influences its ability to invest in marketing and long-term competitiveness. Now we’ll explore how concerns over BJ’s below-industry profit...

Import export and global supply chain stocks are back in focus as the U.S. weighs new tariffs on goods from countries accused of weak enforcement against forced labor, with South Africa pushing hard for an exemption. For investors, that kind of policy shift can quickly reshape costs, margins, and sentiment around companies plugged into cross border trade. This article looks at 3 stocks from our Import Export and Global Supply Chain Stocks screener that appear positioned on the positive side...

Collegium Pharmaceutical (COLL) has drawn fresh interest after recent trading left the stock at about $35.23, with returns mixed across different time frames and investors reassessing how its pain management portfolio supports the current valuation. See our latest analysis for Collegium Pharmaceutical. The recent dip in Collegium Pharmaceutical's share price, with a 1-day share price return of 1.62% down and a 7-day share price return of 4.86% down, sits against a mixed picture where the...

Why TG Therapeutics Stock Is Back in Focus TG Therapeutics (TGTX) has attracted fresh attention after launching a Phase 2 trial of BRIUMVI in adults with treatment-resistant schizophrenia. This extends its CD20-focused approach beyond multiple sclerosis and into severe psychiatric disease. See our latest analysis for TG Therapeutics. The BRIUMVI schizophrenia trial arrives after a strong run in TG Therapeutics' share price, with a 90 day share price return of 69.04% and year to date share...

Earlier this week, Circle Internet Group received final approval from the U.S. Office of the Comptroller of the Currency to establish First National Digital Currency Bank, N.A., which will operate as Circle National Trust and initially provide federally supervised fiduciary digital asset custody for Circle and its affiliates. This charter brings USDC’s core infrastructure into a single federal banking framework, potentially reshaping how regulated institutions access custody and reserve...

Founder led companies can be especially interesting when inflation, rates and growth signals are pulling in different directions, because these leaders typically have both reputation and wealth tied to long term outcomes, not just quarterly bonuses. With central banks weighing softer inflation data against volatile energy prices and uneven growth, many investors are looking for businesses where decision makers are deeply aligned with shareholders. This Founder-Led Companies screener focuses...

Bandwidth stock has surged 430.8% year to date, yet the valuation checks currently lean expensive, which raises the question of how much of the recent optimism is already reflected in the share price. Year to date, Bandwidth has returned 430.8%, which puts recent gains at the center of any discussion about upside from here. The planned $275 million Convertible Senior Notes offering can support funding flexibility, while the added debt and conversion features may weigh on how investors assess...

Williams Companies stock has delivered very strong gains over the past five years, yet the current valuation checks lean expensive. This raises the question of how much of the story is already reflected in the price. Over 5 years, Williams Companies has returned about 273%, which signals that long term shareholders have already enjoyed very substantial value creation. The pending US$5.5b Momentum Midstream acquisition can support expectations for future cash flows, but the integration...

Bio-Rad Laboratories (BIO) has introduced its QX700 System-compatible Vericheck ddPCR Kit portfolio, targeting quality control workflows in advanced cell and gene therapy development and broader biopharma applications, an event that may influence how investors assess the stock. See our latest analysis for Bio-Rad Laboratories. At a share price of US$296.11, Bio-Rad Laboratories has seen modest recent momentum, with a 30-day share price return of 1.75% and a 90-day gain of 6.04%. The 1-year...

Axon Enterprise (NasdaqGS:AXON) has appointed Vivek Mohindra and Eiso Kant as independent directors to its board. The new directors bring experience in large technology companies, AI, and cloud infrastructure startups. The appointments are intended to deepen Axon's governance and oversight around AI and enterprise technology. Axon Enterprise, known for its public safety hardware and software platforms, is trying to position itself more firmly at the intersection of policing tools and AI...

In late June 2026, W. P. Carey Inc. completed a fixed-income offering of 5.200% senior unsecured fixed-rate notes due September 15, 2036, raising about US$346.55 million at a modest discount to par. This long-dated, callable bond issue highlights how W. P. Carey is using unsecured debt to support its capital needs while balancing flexibility and funding costs. We’ll now explore how this new US$346.55 million senior unsecured bond affects W. P. Carey’s investment narrative and risk-reward...

Government pressure on US companies to cut prices, rising fuel costs linked to war with Iran, and fresh tariffs are making inflation a political and corporate headache. Utilities sit at the crossroads of essential services and policy risk, where price controls, tariffs and input costs can all affect how stable a stock feels in a portfolio. This article looks at how those forces connect to a curated screener of larger US utilities stocks, and highlights three stocks that appear positively...

In 2024, agilon health reported that its eight REACH Accountable Care Organizations generated US$229 million in gross savings and achieved a 96% average quality score while managing care for about 121,000 Traditional Medicare beneficiaries under full-risk contracts. This combination of substantial cost savings for Medicare and consistently high quality scores offers a concrete data point on how agilon health’s value-based model can align physician incentives with better outcomes for...

Tariff headlines around South African exports are putting fresh attention on platinum and palladium miners, especially those that feed into U.S. supply chains. A proposed 12.5% U.S. tariff on certain imports, alongside questions around trade preferences and forced labor enforcement, could reshape how platinum group metals move across borders. For investors watching platinum and palladium stocks, these shifts may create both potential openings and new risks. This article looks at three stocks...

Nurix Therapeutics (NRIX) has drawn fresh attention after reporting second quarter 2026 results alongside a new global partnership with Roche for its BTK degrader bexobrutideg, combining scientific ambitions with changing financial signals. See our latest analysis for Nurix Therapeutics. Nurix Therapeutics’ share price has been volatile around the latest quarter, with the stock down 6.6% on the day and 3.8% over the past week, but still showing a 50.7% 1 month share price return and an 85.4%...

Earlier this week, shares of Valaris and other oilfield services firms reacted to President Trump's declaration that the Iran ceasefire was over and threats of renewed strikes, which pushed oil prices higher and highlighted the sensitivity of offshore drillers to geopolitical risk premiums. Separately, Valaris recently confirmed it will release its second-quarter 2026 results after the NYSE close on August 5, 2026, and, amid its pending all-stock business combination with Transocean, no...

In the past week, PagSeguro Digital Ltd. (PAGS) gained momentum as analysts highlighted expectations for its upcoming earnings, projecting earnings of US$0.40 per share on revenue of US$1.05 billion and assigning the stock a favorable ranking. This analyst confidence, centered on anticipated year-over-year improvements in both earnings and revenue, has sharpened investor focus on how effectively PagSeguro is managing profitability ahead of its results. We’ll now examine how this increased...